ADT Biotech has been incorporated in 2010 with the vision of improving the standard of diagnostic tests and procedures by bringing advanced technologies, quality brands and innovative products to the healthcare markets in the Asia Pacific region.

ADT Biotech Sdn Bhd

Multiplexkit for Screening and Confirmation:<ul><li>SARS-related CoV; E-gene</li><li>SARS-CoV-2specific; RdRP-gene</li><li>Internal Control(IC); heterologous RNA</li></ul>HighestAnalytical Sensitivity<ul><li>2.14 cp/μl for E-gene</li><li>1.68 cp/μl for RdRP-gene</li></ul>100% Clinical Sensitivity100% Specificity; no cross reactivity withother human CoV, Influenza and other respiratory viruses and pathogensForRotor-GeneQ(Qiagen), CFx96 (BioRad),Mic (Biomolecular Systems), ABI Prism7500 SDSand QuantStudio 5(Applied Biosystems)CE IVD certified and MDA approved

ADT Biotech Sdn Bhd

Available Products

LyteStarTM 2019-nCoV PCR Kit 2.0